Molecular imaging of cell-mediated cancer immunotherapy

被引:34
|
作者
Lucignani, Giovanni
Ottobrini, Luisa
Martelli, Cristina
Rescigno, Maria
Clerici, Mario
机构
[1] Univ Milan, Inst Radiol Sci, I-20142 Milan, Italy
[2] European Inst Oncol, Unit Mol Imaging, Div Radiat Therapy, I-20141 Milan, Italy
[3] European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy
[4] Univ Milan, Osped L Sacco, Padigl LITA, I-20154 Milan, Italy
关键词
D O I
10.1016/j.tibtech.2006.07.003
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
New strategies based on the activation of a patient's immune response are being sought to complement present conventional exogenous cancer therapies. Elucidating the trafficking pathways of immune cells in vivo, together with their migratory properties in relation to their differentiation and activation status, is useful for understanding how the immune system interacts with cancer. Methods based on tissue sampling to monitor immune responses are inadequate for repeatedly characterizing the responses of the immune system in different organs. A solution to this problem might come from molecular and cellular imaging - a branch of biomedical sciences that combines biotechnology and imaging methods to characterize, in vivo, the molecular and cellular processes involved in normal and pathologic states. The general concepts of noninvasive imaging of targeted cells as well as the technology and probes applied to cell-mediated cancer immunotherapy imaging are outlined in this review.
引用
收藏
页码:410 / 418
页数:9
相关论文
共 50 条
  • [41] T cell-mediated immune responses in melanoma: implications for immunotherapy
    Wang, RF
    Zeng, G
    Johnston, SF
    Voo, K
    Ying, H
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2002, 43 (01) : 1 - 11
  • [42] Advances and challenges in CAR-T cell-mediated immunotherapy
    Rudra, Dipayan
    Kumar, Himanshu
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2022, 41 (06) : 565 - 566
  • [43] New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapy
    Vittore Cereda
    Diane J. Poole
    Claudia Palena
    Sudipto Das
    Tapan K. Bera
    Cinzia Remondo
    James L. Gulley
    Philip M. Arlen
    Junko Yokokawa
    Ira Pastan
    Jeffrey Schlom
    Kwong Y. Tsang
    Cancer Immunology, Immunotherapy, 2010, 59 : 63 - 71
  • [44] T cell-mediated immunotherapy of metastases: state of the art in 2005
    Schirrmacher, V
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (08) : 1051 - 1068
  • [45] Elastic Nanovaccine Enhances Dendritic Cell-Mediated Tumor Immunotherapy
    Li, Qiang
    Teng, Zhaogang
    Tao, Jun
    Shi, Wenhui
    Yang, Guangwen
    Zhang, Yu
    Su, Xiaodan
    Chen, Lin
    Xiu, Weijun
    Yuwen, Lihui
    Dong, Heng
    Mou, Yongbin
    SMALL, 2022, 18 (32)
  • [46] Optimisation of RNA loading for dendritic cell-mediated adoptive immunotherapy
    Hsu, A
    Kerr, B
    Allan, C
    Hart, D
    Rice, A
    BONE MARROW TRANSPLANTATION, 2004, 33 : S303 - S303
  • [47] Molecular imaging to support cancer immunotherapy
    van de Donk, Pim P.
    Oosting, Sjoukje F.
    Knapen, Daan G.
    van der Wekken, Anthonie J.
    Brouwers, Adrienne H.
    Lub-de Hooge, Marjolijn N.
    de Groot, Derk-Jan A.
    de Vries, Elisabeth G. E.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (08)
  • [48] Molecular Imaging of Immunotherapy Targets in Cancer
    Ehlerding, Emily B.
    England, Christopher G.
    McNeel, Douglas G.
    Cai, Weibo
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (10) : 1487 - 1492
  • [49] Allogeneic cell-mediated immunotherapy for breast cancer after autologous stem cell transplantation: A clinical pilot study
    Or, R
    Ackerstein, A
    Nagler, A
    Kapelushnik, J
    Naparstek, E
    Samuel, S
    Amar, A
    Bruatbar, C
    Slavin, S
    CYTOKINES CELLULAR & MOLECULAR THERAPY, 1998, 4 (01) : 1 - 6
  • [50] Optimization of Natural Killer T Cell-Mediated Immunotherapy in Cancer Using Cell-Based and Nanovector Vaccines
    Faveeuw, C.
    Trottein, F.
    CANCER RESEARCH, 2014, 74 (06) : 1632 - 1638